retatrutide glp-1 gip glucagon receptor agonist triple Sweet Temptation, bitter Truth: Diabetes in the Research Spotlight Retatrutide vs. Tirzepatide: The Next-Gen

Currently, most all GLP1 receptor agonists require subcutaneous injections, which is a dealbreaker for a segment of the population that does not want to perform self-injections

While this makes Orforglipron more convenient, it is also less potent. As noted above, unlike some existing oral GLP-1 therapies, Foundayo can be taken any time of day without restrictions on food and water intake, which may improve adherence for some individuals

How Does Retatrutide Work

[DOI] [PMC free article] [PubMed] [Google Scholar] 93.Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA